ALB and acute kidney injury: Methods: Mice were randomly divided into eight groups, dosed daily as follows: Group 1—CTRL (control; vehicle only); Groups 2—A100, 3—A1252x, and 4—A250 (dosed with 100, 125 twice daily, and 250 mg/kg, per os anethole); Group 5—SUBAKI (i.p. albumin to induce hyperproteinemia and proteinuria; subclinical acute kidney injury); and Groups 6—SUBAKI+A100, 7—SUBAKI+A1252x, and 8—SUBAKI+A250 (per os anethole + i.p. albumin).